TearScience Secures Up to $70 Million in Funding
The privately held medical device company
TearScience, Inc., announced that it has secured up to $70
million in funding from HealthCare Royalty Partners to
fully implement the company’s commercialization efforts
and establish the TearScience system as the standard of
care for evaporative dry eye disease (DED). Accord...